Home/Filings/4/0001225208-23-008459
4//SEC Filing

McEvoy Ashley 4

Accession 0001225208-23-008459

CIK 0000200406other

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 4:07 PM ET

Size

6.8 KB

Accession

0001225208-23-008459

Insider Transaction Report

Form 4
Period: 2023-08-23
McEvoy Ashley
EVP, WW Chair, Medical Devices
Transactions
  • Disposition to Issuer

    Common Stock

    2023-08-232,78752,037.955 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    2,806
  • Common Stock

    (indirect: By ESOP)
    300
Footnotes (4)
  • [F1]The Compensation & Benefits Committee of the Board of Directors of Johnson & Johnson approved the disposition of these shares of Johnson & Johnson common stock.
  • [F2]On August 23, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. (Kenvue) common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer.
  • [F3]Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2023).
  • [F4]Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (7/31/2023).

Documents

1 file

Issuer

JOHNSON & JOHNSON

CIK 0000200406

Entity typeother

Related Parties

1
  • filerCIK 0001745936

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:07 PM ET
Size
6.8 KB